ContextVision Q4 and 12 months result 2009

Highlights from the COV Q4 report - Quarterly sales of 16.1 MSEK - Q4 operating margin of -1,5% - SharpView AB recorded as an associated company - Strong GOPView®iRVPlus (fluoroscopy) sales start - The process to evaluate a merger or other strategic opportunity is moving forward, managed by Nomura Code Securities, a leading European Healthcare Investment Bank. Announcement on outcome is expected by the end of first quarter 2010. Please find the report and the presentation attached. For a web-cast presentation, please follow the link on www.contextvision.se, News section